TAK Takeda Pharmaceutical Co. Ltd.
Health Care, filed as TAKEDA PHARMACEUTICAL CO LTD (SPONSORED ADS), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab
In 2026 Q2 Richard Pzena added to Takeda Pharmaceutical.
Who owns TAK
Sorted by value, long equity only, as of 2026 Q2.
| History | |||||
|---|---|---|---|---|---|
| Richard Pzena, Pzena Investment Management | Add +33.4% | 37,820 | $606K | History |
Insider trades
Open-market buys and sales by TAK's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $1.8M sold by 3 insiders outside a trading plan
- $2.5M sold by 1 insider under 10b5-1 plans
-
Lauren Rusckowski Duprey Chief Transformation OfficerSale$640K 34,535 shares at $18.54 15% of stakeTraded Sep 14 Filed Sep 15
-
Andrew Stewart Plump President, R&DPlanned sale$2.1M 116,191 shares at $18.49 44% of stakeTraded Sep 2 Filed Sep 3
-
Andrew Stewart Plump President, R&DPlanned sale$363K 19,651 shares at $18.49 7% of stakeTraded Aug 19 Filed Aug 21
-
Nicola Deidre Petal Greenway Chief Human Resources OfficerSale$235K 12,980 shares at $18.11 25% of stakeTraded Aug 18 Filed Aug 19
-
Elaine Mary Shannon Pres., Global Supply & QualitySale$357K 20,363 shares at $17.55 23% of stakeTraded Aug 11 Filed Aug 12
-
Nicola Deidre Petal Greenway Chief Human Resources OfficerSale$606K 34,603 shares at $17.51 37% of stakeTraded Aug 10 Filed Aug 12
Also filed in the last 12 months, not counted as buying or selling: 35 stock grants and 13 sales to cover taxes.
Congress
1 member of Congress traded TAK in the last three years: 1 buy and 0 sales.
- Alan Armstrong Buy $1K–$15K Mar 30 filed Jul 21
SEC filings
Recent issuer filings from EDGAR, 6 shown.
Ownership over time
13Fs that reported it each quarter. Click a bar for that quarter’s holders.